News|Articles|February 1, 2002
- Pharmaceutical Technology-02-02-2002
- Volume 26
- Issue 2
Available Guidance and Best Practices for Conducting Forced Degradation Studies
Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Advertisement
Articles in this issue
about 24 years ago
Using Earned-Value Analysis to Better Manage Projectsabout 24 years ago
Microbial Bioburden on Oral Solid Dosage Formsabout 24 years ago
Modernizing Pharmaceutical Manufacturingabout 24 years ago
The Role of Computational Fluid Dynamics in the Pharmaceutical Industryabout 24 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Women in STEM: Early Phase Drug Development
3
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
4
PharmTech Weekly Roundup - February 6, 2026
5